SS-31 + CARDIOGEN | 30 Mg Pen

SS-31 (Elamipretide) is a mitochondria-targeting peptide studied for its role in cellular energy regulation and oxidative stress pathways, while Cardiogen is a peptide studied in cardiac-tissue research for its involvement in myocardial signaling and cardiovascular support models. Together, this combination is evaluated in research environments focused on mitochondrial function, cardiac-cell activity, and systemic energy dynamics. Information on this page is provided for scientific and educational context only and does not represent medical guidance or therapeutic claims.

SUPPORTS
Mitochondrial function assessed via ATP production and oxidative phosphorylation markers.
Cellular energy regulation studied through bioenergetic and metabolic endpoints.
Cardiac-cell signaling evaluated in myocardial tissue research frameworks.
Oxidative stress response measured via reactive oxygen species and redox balance markers.
Cardiovascular system support studied through heart-function and tissue-response models.

DESCRIPTION
SS-31, also known as Elamipretide, is a peptide studied for its ability to target mitochondria and interact with cardiolipin, a key phospholipid in the inner mitochondrial membrane. This interaction has been explored in research models where improved mitochondrial efficiency and reduced oxidative stress are measured. Cardiogen is a peptide studied for its potential role in cardiac-tissue signaling and myocardial support within experimental frameworks. In combination, SS-31 and Cardiogen form a dual-pathway system focused on cellular energy production and cardiovascular-related signaling. This blend is used in research environments investigating how mitochondrial performance and cardiac function interact at the cellular level. This product is presented for controlled research and educational context only and is not marketed as a therapeutic intervention.

CLINICAL STATUS
SS-31 has been studied in both clinical and preclinical settings, particularly in mitochondrial dysfunction and cardiovascular-related research. Cardiogen research is primarily preclinical and mechanistic. The combined formulation remains within experimental research contexts and is not approved as a general therapeutic product.

Evidence type: Human RCT ✔ (SS-31) | Observational ✔ | Animal ✔ | In vitro ✔ | Regulatory approval ✘

MECHANISM OF ACTION
Mechanistic models of SS-31 focus on its selective targeting of mitochondrial membranes, where it binds to cardiolipin and stabilizes electron transport chain function, improving ATP production and reducing reactive oxygen species. Cardiogen is studied for its interaction with signaling pathways associated with cardiac-cell activity and myocardial function. Together, the peptides are evaluated as a system that supports cellular energy efficiency while influencing cardiac-related signaling pathways. Effects are measured through mitochondrial performance markers, oxidative stress indicators, and cardiac-cell activity models.

BENEFITS
Mitochondrial Efficiency Research: SS-31 is studied for improving mitochondrial function and ATP production.
Cellular Energy Support: Evaluated in models focused on bioenergetics and energy utilization.
Cardiac Signaling Research: Cardiogen is studied for its effects on myocardial-cell communication.
Oxidative Stress Reduction: Research indicates reduced reactive oxygen species in mitochondrial models.
Cardiovascular Research Applications: Explored in models assessing heart-related cellular activity.
Dual-System Integration: Combines mitochondrial targeting with cardiac signaling pathways in one framework.

RESEARCH DATA
Study/model | Reported effect
Mitochondrial function studies | Improved ATP production and reduced oxidative stress observed
Cardiac-cell models | Enhanced signaling and cellular response in myocardial tissue
Preclinical cardiovascular studies | Improved cellular energy and function markers
In vitro assays | Stabilization of mitochondrial membranes and reduced ROS levels

STACK SUGGESTIONS
NAD+ (cellular energy and mitochondrial function models)
CoQ10 (electron transport chain and oxidative balance research)
Glutathione (redox balance and oxidative stress studies)
Stacks discussed are for experimental design only, not safety or efficacy guidance.

POSSIBLE SIDE EFFECTS
Injection-site reactions including redness or discomfort
Transient fatigue or energy fluctuations
Mild systemic adjustments depending on protocol
Responses vary depending on experimental conditions

SCIENTIFIC REFERENCES
SS-31 mitochondrial targeting studies — Clinical and preclinical research
Cardiolipin interaction and mitochondrial function — Mechanistic studies
Cardiac-cell signaling research — Experimental models
Oxidative stress and mitochondrial efficiency — Translational data

CAUTIONS
For educational and scientific context only; not intended to diagnose, treat, cure, or prevent any disease. Not approved for general medical use. Outcomes vary based on experimental design and physiological conditions. Consult a qualified professional for any health-related decisions.